MXene-TA regulates NAD+ levels and promotes the binding of NAD+ and CX43, thereby increasing the synthesis and release of SDF-1, significantly prolonging the survival time of ADSC and supporting its ability to repair MI tissues and prevent fibrosis. The gene discussed is CXCL12; the disease is myocardial infarction.